Meanwhile, we divided HNSCC patients into four subgroups based on TP53 and TTN mutational status, and then analyzed the effect of risk score on the survival of HNSCC patients within each subgroup. The gene discussed is TTN; the disease is head and neck squamous cell carcinoma.